Mackay Shields LLC’s Chemed CHE Stock Holding History

Mackay Shields LLC’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,283	Closed	-$556K	–	1473
2020 Q1	$556K	Buy	+1,283	New	+$573K	0.01%	1104

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mackay Shields LLC's CHE Position: Q2 2020 in Review

Mackay Shields LLC sold out of Chemed (CHE) in Q2 2020, closing a stake of 1,283 shares — an estimated $556K sold.

Mackay Shields LLC first reported a position in CHE in Q1 2020 and held it in 1 quarter. The position peaked at $556K in Q1 2020. 425 funds tracked by Wall St. Rank hold CHE as of Q2 2020.

Mackay Shields LLC reported no remaining Chemed position as of Q2 2020 after selling out during the quarter.
Mackay Shields LLC sold 1,283 Chemed shares in Q2 2020, an estimated $556K.
Mackay Shields LLC first reported a position in Chemed in Q1 2020 and held it in 1 quarter.
Mackay Shields LLC's Chemed position peaked at $556K in Q1 2020.
425 funds tracked by Wall St. Rank held Chemed as of Q2 2020.

Based on Mackay Shields LLC's 13F filing for Q2 2020, filed 31 Jul 2020.